Results 101 to 110 of about 57,467,955 (246)
Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing. [PDF]
Host defense peptides, in particular LL-37, are emerging as potential therapeutics for promoting wound healing and inhibiting bacterial growth. However, effective delivery of the LL-37 peptide remains limiting.
Becerikli, Mustafa +12 more
core +1 more source
The Novel Viral Non‐Coding RNA LMP2A‐IT1 Promotes the Lytic Replication of EBV
Decades after its discovery, EBV's genome still harbours unannotated “dark matter”. LMP2A‐IT1, a novel EBV‐encoded transcript identified in this work, is strongly upregulated during lytic replication and promotes BZLF1 expression, likely through activation of inflammatory responses, thereby enhancing viral propagation in a self‐reinforcing positive ...
Zheng‐Zhou Lu +15 more
wiley +1 more source
CKMT1 inhibits VDAC1 oligomerization via a dual‐region mechanism: its NTD interacts with the VDAC1 C‐terminal domain, while residues 1–39 sterically hinder dimerization, thereby reducing mtDNA leakage and AIM2 inflammasome activation, suppressing neuronal pyroptosis and protecting against cerebral ischemic injury. ABSTRACT Ischemic stroke is one of the
Xiaoyu Wang +17 more
wiley +1 more source
Human cathelicidin LL-37, a host defense peptide derived from leukocytes and epithelial cells, plays a crucial role in innate and adaptive immunity.
Betancourt, Aline M. +9 more
core +1 more source
ARGININE-LYSINE SWAPS SELECTIVELY ENHANCE ANTIMICROBIAL ACTIVITY OVER CYTOTOXIC ACTIVITY OF LL-37 [PDF]
LL-37 is the only cationic peptide belonging to the cathelicidin family expressed in humans. LL-37 has bactericidal activity and exerts immunomodulatory functions forming, together with other peptides, the first line of defense against infections.
Enrico Balducci +2 more
core +1 more source
Background: Now a day, antibiotic resistance is a global problem. A way to solve this problem is production of alternative drugs. In this regard, today so many researches on antimicrobial peptides against pathogens are being done. LL-37 peptide is one of
Ehsan Zarei-Mehrvarz +3 more
doaj
Cubosomes for topical delivery of the antimicrobial peptide LL-37
In this study, the use of cubosomes for topical delivery of the antimicrobial peptide (AMP) LL-37 was investigated. Topical delivery of AMPs is of great interest for treatment of skin infections caused by bacteria, such as Staphylococcus aureus.
Davoudi, Mina +30 more
core +1 more source
The Role of Bacterial Filamentation in Response to the Antimicrobial Peptide LL-37
Urinary tract infections (UTIs) are one of the most common bacterial infections in humans. Uropathogenic E. coli (UPEC) are the primary cause of UTIs. During a UTI, UPEC invades bladder epithelial cells forming intracellular biofilm-like structures with ...
Madison Tomlinson (18162091)
core +1 more source
The increasing prevalence of antimicrobial resistance and endotoxin-mediated inflammation highlights the need for alternative therapeutic strategies that combine antibacterial and immunomodulatory functions.
Baseer Ahmad +8 more
doaj +1 more source
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by an impaired epidermal barrier, dysregulation of innate and adaptive immunity, and a high susceptibility to bacterial colonization and infection.
Andreas Sonesson +7 more
doaj +1 more source

